36
Participants
Start Date
July 21, 2021
Primary Completion Date
July 21, 2026
Study Completion Date
July 21, 2026
Treatment by regorafenib and best supportive care
"Treatment for 13 cycles (12 months) maximum.~During each cycle :~* patients ≥ 16 years old and patients \<16 old with Body Surface Area (BSA) ≥ 1,70 m2 will take 3 tablets, once a day, corresponding to a total of 120 mg Regorafenib, during 21 days, followed by 7 days without treatment.~* patients \< 16 years old with a 1,30 m2 ≤ BSA ≥ 1,70 m2 will take 2 tablets, once a day, corresponding to a total of 80 mg Regorafenib, during 21 days, followed by 7 days without treatment"
RECRUITING
Hopital de La Timone, Marseille
NOT_YET_RECRUITING
Centre Georges Francois Leclerc, Dijon
NOT_YET_RECRUITING
Chu Besancon, Besançon
RECRUITING
Iuct Oncopole, Toulouse
RECRUITING
Institut Bergonie, Bordeaux
NOT_YET_RECRUITING
Icm Val D'Aurelle, Montpellier
NOT_YET_RECRUITING
Chu Saint-Etienne, Saint-Priest-en-Jarez
NOT_YET_RECRUITING
Hotel Dieu Nantes, Nantes
RECRUITING
Ico Rene Gauducheau, Saint-Herblain
NOT_YET_RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
CHRU Hôpital Hautepierre, Strasbourg
NOT_YET_RECRUITING
ICANS, Strasbourg
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Institut Curie, Paris
RECRUITING
Hôpital COCHIN, Paris
NOT_YET_RECRUITING
Institut Gustave Roussy, Villejuif
Centre Leon Berard
OTHER